CASP3 and cancer: H&E staining, along with the expression of cleaved caspase-3 as a positive marker for the efficiency of cancer treatment (72), revealed that there was a remarkable increase in the apoptotic index of caspase-3 in the combination group, suggesting in situ cell apoptosis compared with treatment with single agonists (Figure 6).